Financhill
Sell
39

MTSR Quote, Financials, Valuation and Earnings

Last price:
$44.28
Seasonality move :
--
Day range:
$39.40 - $44.45
52-week range:
$12.30 - $46.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.21x
Volume:
689.8K
Avg. volume:
976.3K
1-year change:
--
Market cap:
$4.7B
Revenue:
--
EPS (TTM):
-$2.20
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $15.6M $107.5M
Selling, General & Admin -- -- -- $15M $26.8M
Other Inc / (Exp) -- -- -- -$18.5M -$90.1M
Operating Expenses -- -- -- $30.6M $134.3M
Operating Income -- -- -- -$30.6M -$134.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$47.2M -$218.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$9.3M
Net Income to Company -- -- -- -$47.2M -$209.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$47.2M -$209.1M
 
Basic EPS (Cont. Ops) -- -- -- -$0.95 -$2.03
Diluted EPS (Cont. Ops) -- -- -- -$0.95 -$2.03
Weighted Average Basic Share -- -- -- $49.9M $103M
Weighted Average Diluted Share -- -- -- $49.9M $103M
 
EBITDA -- -- -- -$47.2M -$218.2M
EBIT -- -- -- -$47.2M -$218.2M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$30.6M -$134.3M
Operating Income (Adjusted) -- -- -- -$47.2M -$218.2M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $17.8M $57.2M
Selling, General & Admin -- -- -- $4.1M $8.6M
Other Inc / (Exp) -- -- -- $824K -$15.6M
Operating Expenses -- -- -- $21.9M $65.8M
Operating Income -- -- -- -$21.9M -$65.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$20.2M -$76.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$291K --
Net Income to Company -- -- -- -$19.9M -$76.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$19.9M -$76.6M
 
Basic EPS (Cont. Ops) -- -- -- -$0.40 -$1.03
Diluted EPS (Cont. Ops) -- -- -- -$0.40 -$1.03
Weighted Average Basic Share -- -- -- $49.9M $74.4M
Weighted Average Diluted Share -- -- -- $49.9M $74.4M
 
EBITDA -- -- -- -$20.2M -$76.5M
EBIT -- -- -- -$20.2M -$76.5M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$21.9M -$65.8M
Operating Income (Adjusted) -- -- -- -$20.2M -$76.5M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- $121.5M
Selling, General & Admin -- -- -- -- $26.1M
Other Inc / (Exp) -- -- -- -$1.8M -$32.9M
Operating Expenses -- -- -- -- $147.6M
Operating Income -- -- -- -- -$147.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$171.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$8.7M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$162.4M
 
Basic EPS (Cont. Ops) -- -- -- -- -$2.20
Diluted EPS (Cont. Ops) -- -- -- -- -$2.20
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- -$257M
EBIT -- -- -- -- -$257.1M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- -$147.6M
Operating Income (Adjusted) -- -- -- -- -$257.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $17.8M $57.2M
Selling, General & Admin -- -- -- $4.1M $8.6M
Other Inc / (Exp) -- -- -- $824K -$15.6M
Operating Expenses -- -- -- $21.9M $65.8M
Operating Income -- -- -- -$21.9M -$65.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$20.2M -$76.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$291K --
Net Income to Company -- -- -- -$19.9M -$76.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$19.9M -$76.6M
 
Basic EPS (Cont. Ops) -- -- -- -$0.40 -$1.03
Diluted EPS (Cont. Ops) -- -- -- -$0.40 -$1.03
Weighted Average Basic Share -- -- -- $49.9M $74.4M
Weighted Average Diluted Share -- -- -- $49.9M $74.4M
 
EBITDA -- -- -- -$20.2M -$76.5M
EBIT -- -- -- -$20.2M -$76.5M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$21.9M -$65.8M
Operating Income (Adjusted) -- -- -- -$20.2M -$76.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- -- $15M $75.2M $352.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $848K $2.1M
Other Current Assets -- -- -- $761K $1.6M
Total Current Assets -- -- $15M $76.8M $359.1M
 
Property Plant And Equipment -- -- -- $27K $1.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- $22.2M $21.9M
Other Intangibles -- -- -- $69.4M $68.5M
Other Long-Term Assets -- -- -- $410K --
Total Assets -- -- $15M $168.8M $451M
 
Accounts Payable -- -- -- $2.7M $20.8M
Accrued Expenses -- -- $96K $1.7M $11.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $714K
Other Current Liabilities -- -- -- $13.3M $19.1M
Total Current Liabilities -- -- $613K $20.2M $67.3M
 
Long-Term Debt -- -- $15.2M -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $15.8M $70.3M $163.6M
 
Common Stock -- -- -- $143.7M $540.9M
Other Common Equity Adj -- -- -- $2.8M $1.2M
Common Equity -- -- -$813K -$45.2M -$253.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -$813K $98.5M $287.4M
 
Total Liabilities and Equity -- -- $15M $168.8M $451M
Cash and Short Terms -- -- $15M $75.2M $352.4M
Total Debt -- -- -- -- --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents -- -- -- -- $588.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $4.8M
Other Current Assets -- -- -- -- $1.6M
Total Current Assets -- -- -- -- $594.7M
 
Property Plant And Equipment -- -- -- -- $1.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- $22.5M
Other Intangibles -- -- -- -- $70.6M
Other Long-Term Assets -- -- -- -- $1.6M
Total Assets -- -- -- -- $690.7M
 
Accounts Payable -- -- -- -- $15.2M
Accrued Expenses -- -- -- -- $27.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $727K
Other Current Liabilities -- -- -- -- $34.9M
Total Current Liabilities -- -- -- -- $90.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $185.3M
 
Common Stock -- -- -- -- $1K
Other Common Equity Adj -- -- -- -- $5.3M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- $43.4M --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $505.4M
 
Total Liabilities and Equity -- -- -- -- $690.7M
Cash and Short Terms -- -- -- -- $588.3M
Total Debt -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- -- -$47.2M -$209.1M
Depreciation & Amoritzation -- -- -- $2K $14K
Stock-Based Compensation -- -- -- $85K $2.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$35.4M -$100M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -$28.2M --
Cash From Investing -- -- -- -$28.2M -$43K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$217K -$19.8M
Cash From Financing -- -- -- $123.7M $378.2M
 
Beginning Cash (CF) -- -- -- $15M $75.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $60M $278.1M
Ending Cash (CF) -- -- -- $75.2M $352.4M
 
Levered Free Cash Flow -- -- -- -$35.4M -$100.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -$19.9M -$76.6M
Depreciation & Amoritzation -- -- -- $1K $5K
Stock-Based Compensation -- -- -- $79K $2.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$15.8M -$54.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$515K --
Cash From Financing -- -- -- $42.9M $288.6M
 
Beginning Cash (CF) -- -- -- $75.2M $352.4M
Foreign Exchange Rate Adjustment -- -- -- -$30K $1.7M
Additions / Reductions -- -- -- $27.1M $234.2M
Ending Cash (CF) -- -- -- $102.3M $588.3M
 
Levered Free Cash Flow -- -- -- -$15.8M -$54.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- $79K $2.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$155.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -$19.9M -$76.6M
Depreciation & Amoritzation -- -- -- $1K $5K
Stock-Based Compensation -- -- -- $79K $2.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$15.8M -$54.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$515K --
Cash From Financing -- -- -- $42.9M $288.6M
 
Beginning Cash (CF) -- -- -- $75.2M $352.4M
Foreign Exchange Rate Adjustment -- -- -- -$30K $1.7M
Additions / Reductions -- -- -- $27.1M $234.2M
Ending Cash (CF) -- -- -- $102.3M $588.3M
 
Levered Free Cash Flow -- -- -- -$15.8M -$54.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

Buy
72
MNPR alert for Jul 18

Monopar Therapeutics [MNPR] is up 13.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock